0.7506USD-4.42%Mkt Cap: 33.60M $P/E: —1d ago
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's a…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap33.60M $
Enterprise Value51.85M $
Revenue (TTM)80.81M $
Gross Profit54.34M $
Net Income (TTM)-38.83M $
Revenue/Share1.618 USD
Last Price0.7506 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees218
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.35
PEG—
EV/EBITDA-1.58
EV/Revenue0.64
P/S0.42
P/B-6.47
EPS (TTM)-0.79
EPS (Forward)-0.56
52W Range
0.501015% of range2.186
52W High2.186 USD
52W Low0.5010 USD
Profitability
Gross Margin67.69%
Oper. Margin-55.23%
EBITDA Margin-40.59%
Profit Margin-48.37%
ROE-615.10%
ROA-47.69%
Growth
Revenue Growth2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.22M $
CapEx (TTM)448.00K $
FCF Margin-21.58%
FCF Yield-51.89%
Net Debt18.25M $
Net Debt/EBITDA-0.56
Balance Sheet
Debt/Equity8.90
Current Ratio3.61
Quick Ratio2.76
Book Value/Sh-0.1160 USD
Cash/Share0.8830 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.250 USD
Upside (mean)+199.8%
Target Range1.000 USD – 3.250 USD
$1.000+199.8% to mean$3.250
# Analysts5
Ownership
Shares Out.44.77M
Float20.01M
Insiders7.66%
Institutions68.92%
Short Interest
Short Ratio3.9d
Short % Float1.51%
Short % Out.1.04%
Shares Short466.22K
Short (prev mo.)748.09K
Technical
SMA 500.8743 (-14.1%)
SMA 2000.9856 (-23.8%)
Beta1.34
S&P 52W Chg20.25%
Avg Vol (30d)104.03K
Avg Vol (10d)73.86K
Technical Indicators
RSI (14)44.4
MACD-0.0174
MACD Signal-0.0192
MACD Hist.+0.0019
BB Upper0.9048 USD
BB Middle0.7877 USD
BB Lower0.6707 USD
BB Width29.71%
ATR (14)0.0962 USD
Vol Ratio (20d)0.51x